Relevant bibliographies by topics / Communicable diseases

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Communicable diseases'

Author: Grafiati
Published: 4 June 2021
Last updated: 31 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Communicable diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Communicable diseases"

1

Djajalaksana, Susanthy. "Communicable vs Non-communicable Diseases." Jurnal Klinik dan Riset Kesehatan 3, no. 3 (June 25, 2024): 150–52. http://dx.doi.org/10.11594/jk-risk.03.3.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bertin, Mary L. "COMMUNICABLE DISEASES." Nursing Clinics of North America 34, no. 2 (June 1999): 509–26. http://dx.doi.org/10.1016/s0029-6465(22)02397-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mongold, Susan. "Communicable Diseases." Journal of Consumer Health On the Internet 11, no. 3 (October 9, 2007): 75–84. http://dx.doi.org/10.1300/j381v11n03_05.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hardy, Erica, and Brenna Anderson. "Communicable Diseases." Seminars in Reproductive Medicine 33, no. 01 (January 7, 2015): 030–34. http://dx.doi.org/10.1055/s-0034-1395276.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Walsh, Kieran. "Serious communicable diseases." BMJ 328, no. 7447 (April 29, 2004): 1045. http://dx.doi.org/10.1136/bmj.328.7447.1045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sobol, I. "Reporting communicable diseases." Canadian Medical Association Journal 174, no. 4 (February 14, 2006): 500. http://dx.doi.org/10.1503/cmaj.1050270.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Longbottom, Helen. "Communicable Diseases Intelligence." Emerging Infectious Diseases 1, no. 1 (March 1995): 36. http://dx.doi.org/10.3201/eid0101.950109.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Schwamm, Lee H. "The communicable nature of non-communicable diseases." Lancet Neurology 17, no. 8 (August 2018): 665. http://dx.doi.org/10.1016/s1474-4422(18)30216-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chaulk, C. Patrick, and Nancy G. Baruch. "When communicable and non-communicable diseases collide." International Journal of Tuberculosis and Lung Disease 19, no. 7 (July 1, 2015): 749. http://dx.doi.org/10.5588/ijtld.15.0454.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sarwat, Maryam, and Munir Ozturk. "Molecular Signaling During Communicable and Non-communicable Diseases." Current Pharmaceutical Design 26, no. 4 (March 18, 2020): 395. http://dx.doi.org/10.2174/138161282604200306111452.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Communicable diseases"

1

Wright, Rosemary Jean. "Applied epidemiology of communicable and non-communicable diseases, Victoria, 2016–2017." Master's thesis, Canberra, ACT : The Australian National University, 2018. http://hdl.handle.net/1885/154287.

Full text
Abstract:
In this thesis, I present the projects and activities I have undertaken as a Master of Philosophy in Applied Epidemiology (MAE) Scholar in Victoria between February 2016 and November 2017. I was placed with the Environmental and Genetic Epidemiology Research Group at the Murdoch Childrens Research Institute (MCRI), and the Communicable Disease Epidemiology and Surveillance Unit at the Victorian Department of Health and Human Services (DHHS). At MCRI I worked on the Barwon Infant Study, a birth cohort study designed to investigate how early life environment can influence the development of immune disorders and neurodevelopmental outcomes. At DHHS, I had the opportunity to lead an outbreak investigation, undertake an evaluation of a public health surveillance system, and an epidemiological study. Through these placements I experienced the day-to-day activities of a research institute and a state public health unit. At MCRI I conducted a data analysis on the prevalence of aero-allergen sensitisation in infancy in the Barwon region in Victoria. Sensitisation to aero-allergens in infancy is considered rare and as a result few studies report the prevalence in infants. My data fills this gap in the literature using data from a population-derived cohort study. I reported the findings of this study at the Training Programs in Epidemiology and Public Health Interventions Network Global Scientific Conference, and the Australasian Epidemiological Association Conference in 2017. My surveillance evaluation involved the first stakeholder consultation of the Influenza Complications Alert Network (FluCAN), which was established in 2009 as part of Australia’s response to the A(H1N1/09) pandemic in order to provide sentinel surveillance of influenza requiring hospitalisation. As part of the evaluation I made a number of recommendations to improve the usefulness and operation of the surveillance system many of which have already been implemented. I presented the outcomes of this evaluation to key stakeholders at the annual National Influenza Surveillance Committee in 2017. I conducted an epidemiological study on Shiga toxin-producing Escherichia coli (STEC) using 15 years of Victorian data. The primary aims of this project were to describe the epidemiology of STEC in Victoria and to investigate the length of exclusion of cases in ‘high-risk’ groups (including food handlers, child and health care workers, and children attending child care) by diagnostic method. The results of this study will inform Victoria’s policy regarding the exclusion of cases in these ‘high-risk’ groups from workplaces and child care. I also conducted an outbreak investigation, including a case-control study in order to identify the source of an outbreak of Salmonella Typhimurium at a Melbourne café. The results of the case-control study indicated that hollandaise sauce was the likely cause of the outbreak and led to public health action. The high proportion of cases hospitalised in this outbreak demonstrates the serious health implications of salmonellosis and the potential consequences of deficient storage and food handling processes for high-risk food products such as hollandaise sauce. In this thesis, I present my experience of the MAE program, and demonstrate my fulfillment of the requirements of the program and the contribution my work has made to public health in Victoria.
APA, Harvard, Vancouver, ISO, and other styles
2

Chochó, Karen S. "Hispanic migrants and cross-border disease control of Arizona's vaccine preventable diseases." restricted, 2008. http://etd.gsu.edu/theses/available/etd-04222008-151047/.

Full text
Abstract:
Thesis (M.Ph.)--Georgia State University, 2008.
Title from file title page. Richard Rothenberg, committee chair; Russ Toal, Karen E. Gieseker, committee members. Electronic text (135 p. : col. ill.) : digital, PDF file. Description based on contents viewed August 12, 2008. Includes bibliographical references (p. 127-135).
APA, Harvard, Vancouver, ISO, and other styles
3

Cheung, Ka-nang Benny. "Hospital for infectious diseases." Hong Kong : University of Hong Kong, 1999. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25950927.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lee, Shiu-hung, and 李紹鴻. "Epidemiological surveillance of communicable diseases in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1991. http://hub.hku.hk/bib/B31981458.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

St, George Siobhan Clare. "Applied Epidemiology in Communicable Diseases, Victoria, 2016 - 2017." Master's thesis, Canberra, ACT : The Australian National University, 2018. http://hdl.handle.net/1885/154282.

Full text
Abstract:
This thesis presents the projects and activities I have undertaken throughout 2016-2017 to fulfil the requirements of the Master of Philosophy - Applied Epidemiology (MAE). My placement was shared between OzFoodNet Victoria (within the Victorian Department of Health and Human Services) and the Microbiological Diagnostic Unit Public Health Laboratory (MDU). This shared placement provided me with the unique opportunity to experience the different day-to-day workings of a state health department and a public health reference laboratory, while also experiencing the multitude of ways in which these two organisations work together to protect the health of the Victorian public. In my placement at MDU I completed an evaluation of the Victorian Hospital Pathogens Surveillance Scheme (VHPSS). This scheme has been running since 1988 and collects information on invasive bacterial and fungal infections and their antimicrobial sensitivities in the Victorian population. My evaluation highlighted the value of the VHPSS in collecting information on pathogens not captured by any other surveillance system in Victoria, and made a number of recommendations to improve the function and focus of the scheme, especially in the context of increasing concerns surrounding antimicrobial resistance nationally and globally. In my placement with OzFoodNet Victoria I was involved in the investigation of multiple clusters and outbreaks of enteric disease. In particular, I coordinated the investigation of an outbreak of Salmonella Typhimurium at a Melbourne café which was linked to the consumption of hollandaise sauce. This outbreak highlighted the dangers of improper food handling in preparing and storing partially-cooked egg products, and the limited knowledge many people have about the risks of consuming these foods. Following another Salmonella outbreak, I conducted an epidemiological study on the proportion of outbreak cases who developed symptoms of transient or chronic sequelae following their infection. In particular, this study collected information on symptoms of post-infectious irritable bowel syndrome (PI-IBS) and reactive arthritis (ReA). This study found that in the six months following their Salmonella infection, 18% of study participants experienced new gastrointestinal symptoms consistent with PI-IBS, and 11% of participants experienced new joint symptoms consistent with ReA. Many of these participants were still experiencing these symptoms a year after their Salmonella infection, indicating the development of chronic disease. I also conducted analyses on data from the Victorian Food Frequency Survey. This survey collected information on the consumption of approximately 250 food items in 4008 well Victorian people, so that their food consumption frequencies could be compared to information from Salmonella case interviews (and interviews for cases of other enteric pathogens such as Campylobacter and Shiga-toxin producing Escherichia coli) to assist in generating hypotheses to try and identify sources of infection. I translated this data into an accessible format for use in outbreak investigations, and examined the demographic consumption patterns of various high-risk food items to determine who might be most at risk of infection. These projects, alongside the teaching activities and scientific communications presented in this thesis, fulfil the requirements of the MAE program and will contribute to the public health of Victorians.
APA, Harvard, Vancouver, ISO, and other styles
6

Pressley, Meagan E. "Infectious Disease Models for the Zebrafish." Fogler Library, University of Maine, 2004. http://www.library.umaine.edu/theses/pdf/PressleyME2004.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chen, Qizhi. "Analysis of infectious disease data /." Hong Kong : University of Hong Kong, 2000. http://sunzi.lib.hku.hk/hkuto/record.jsp?B21841627.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ben, Aissa Soler Alejandra. "Rapid diagnostic test for the detection of communicable diseases." Doctoral thesis, TDX (Tesis Doctorals en Xarxa), 2020. http://hdl.handle.net/10803/670392.

Full text
Abstract:
La prevenció i el control de les malalties transmissibles depenen, en gran mesura, de la detecció ràpida i eficaç. Els mètodes convencionals per a la detecció d'un patogen, com ara el cultiu microbiològic, generalment requereixen molt de temps, són laboriosos, necessiten personal qualificat i no són aptes com a eines de diagnòstic en el punt d'atenció. El desenvolupament de mètodes de diagnòstic ràpid en el marc dels criteris ASSURED, de l'anglès (A) Affordable, (SS) Sensitive i Didàctiques, (O) User-friendly, (R) Rapid and Robust, (I) Equipment free, and (d) Deliverable to those who need it, Affordable, descrits per l'Organització Mundial de la Salut (OMS), es troben en l'actualitat sota intens estudi. Per tant, la present tesi aborda el disseny i desenvolupament d'estratègies, mètodes i materials per millorar les prestacions analítiques i simplificar el procediment en proves de diagnòstic ràpid, incloses noves estratègies de preconcentració en fase sòlida, mètodes d'amplificació i materials avançats, així com la seva integració en diferents plataformes (principalment biosensors basats en detecció electroquímica i proves en paper amb lectura òptica). En tots els casos, les aplicacions seleccionades es centren en malalties transmissibles, inclosos els patògens transmesos pels aliments i els micobacteris. Amb aquesta finalitat, es comparen dues plataformes basades en paper en diferents configuracions (flux lateral i vertical) en termes de rendiment analític per a la detecció de Mycobacterium. Per aconseguir una millora addicional en el límit de detecció, s'estudia la preconcentració prèvia dels bacteris per separació immunomagnètica. En segon lloc, s'avaluen i es comparen en termes del seu rendiment analític la detecció simultània de Salmonella i E. coli mitjançant flux lateral d'àcid nucleic amb lectura visual i genosensors electroquímics. Si bé aquests mètodes requereixen PCR de doble etiquetatge per a l'amplificació, es poden adaptar fàcilment a termocicladors portàtils que funcionen amb bateries per poder ser realitzats en entorns amb recursos limitats per satisfer les demandes de diagnòstic ASSURED. A més, també es presenta en aquesta tesi la síntesi de polímers magnètics impresos molecularment, per tal de reemplaçar les partícules magnètiques biològicament modificades, i prenent com a model la detecció de biotina i de molècules biotinilades. A més, es realitza la caracterització del material mitjançant diferents tècniques analítiques i es compara, en tots els casos, amb el polímer no imprès. Aquest material biomimètic mostra un gran potencial per a la preconcentració i detecció d'una àmplia gamma d'analits. Malgrat tot els progressos, les tècniques d'amplificació d'àcid nucleic segueixen essent necessàries per assolir els límits de detecció requerits en algunes malalties transmissibles. En aquest sentit, les tècniques d'amplificació isotèrmiques són bons candidats per dur a terme proves de diagnòstic en entorns on la PCR pot ser una barrera. En concret, es descriu en aquest treball la detecció d' E.coli mitjançant un genosensor electroquímic basat en l'amplificació isotèrmica. En aquest cas, s'optimitza la lectura electroquímica per voltamperometria d'ona quadrada en elèctrodes d'un sol ús comparant dues estratègies de marcatge del producte amplificat. És important ressaltar que totes aquestes estratègies apunten a ser utilitzades com a eines per millorar les proves de diagnòstic ràpid en entorns de baixos recursos, per interrompre la cadena d'infecció de malalties transmissibles i permetre, per tant, un tractament precoç.
La prevención y el control de las enfermedades transmisibles dependen, en gran medida, de la detección rápida y eficaz. Los métodos convencionales para la detección de un patógeno, como el cultivo microbiológico, generalmente requieren mucho tiempo, son laboriosos, necesitan personal cualificado y no son aptos como herramientas de diagnóstico en el punto de atención. El desarrollo de métodos de diagnóstico rápido en el marco de los criterios ASSURED, del inglés (A) Affordable, (SS) Sensitive and Specific, (U) User-friendly, (R) Rapid and Robust, (E) Equipment free, and (D) Deliverable to those who need it, Affordable, descritos por la Organización Mundial de la Salud (OMS), se encuentran en la actualidad bajo intenso estudio. Por lo tanto, la presente tesis aborda el diseño y desarrollo de estrategias, métodos y materiales para mejorar las prestaciones analíticas y simplificar el procedimiento en pruebas de diagnóstico rápido, incluidas nuevas estrategias de preconcentración en fase sólida, métodos de amplificación y materiales avanzados, así como su integración en diferentes plataformas (principalmente biosensores basados en detección electroquímica y pruebas en papel con lectura óptica). En todos los casos, las aplicaciones seleccionadas se centran en enfermedades transmisibles, incluidos los patógenos transmitidas por los alimentos y las micobacterias. Con este fin, se comparan dos plataformas basadas en papel en diferentes configuraciones (flujo lateral y vertical) en términos del rendimiento analítico para la detección de Mycobacterium. Para lograr una mejora adicional en el límite de detección, se estudia la preconcentración previa de las bacterias por separación inmunomagnética. En segundo lugar, se evalúan y se comparan en términos de su rendimiento analítico la detección simultánea de Salmonella y E. coli mediante flujo lateral de ácido nucleico con lectura visual y genosensores electroquímicos. Si bien estos métodos requieren PCR de doble etiquetado para la amplificación, se pueden adaptar fácilmente a termocicladores portátiles que funcionan con baterías para poder ser realizados en entornos con recursos limitados para satisfacer las demandas de diagnóstico ASSURED. Además, también se presenta en esta disertación la síntesis de polímeros magnéticos impresos molecularmente, con el objeto de reemplazar las partículas magnéticas biológicamente modificadas, y tomando como modelo la detección de biotina y moléculas biotiniladas. Además, se realiza la caracterización del material mediante diferentes técnicas analíticas y se compara, en todos los casos, con el polímero no impreso. Este material biomimético muestra un gran potencial para la preconcentración y detección de una amplia gama de analitos. A pesar de todo este progreso, las técnicas de amplificación de ácido nucleico siguen siendo necesarias para alcanzar los límites de detección requeridos en algunas enfermedades transmisibles. Las técnicas de amplificación isotérmica son buenos candidatos para llevar pruebas de diagnóstico en entornos donde la PCR puede ser una barrera. En concreto, se describe en esta disertación la detección de E. coli mediante un genosensor electroquímico basada en la amplificación isotérmica. En este caso, se optimiza la lectura electroquímica por voltamperometría de onda cuadrada en electrodos desechables comparando dos estrategias de marcaje del producto amplificado. Es importante resaltar que todas estas estrategias apuntan a ser utilizadas como herramientas para mejorar las pruebas de diagnóstico rápido en entornos de bajos recursos, para interrumpir la cadena de infección de enfermedades transmisibles y permitir, por tanto, un tratamiento precoz.
The prevention and control of communicable disease rely, to a large extent, on effective and early detection approaches. Conventional methods for the detection of a pathogen, such as microbiological culture, are usually time-consuming, laborious, need skilled personnel and are non-amenable to point-of-care diagnostic tools. The development of rapid diagnostic methods in the framework of the ASSURED criteria as (A) Affordable, (SS) Sensitive and Specific, (U) User-friendly, (R) Rapid and Robust, (E) Equipment free, and (D) Deliverable to those who need it, outlined by the World Health Organization (WHO), are under intensive study. Therefore, the present dissertation addresses the design and development of strategies, methods and materials to improve the analytical performance and to simplify the analytical procedure in rapid diagnostic tests, including novel solid-phase preconcentration strategies, amplification methods and advanced materials, as well as their integration in different platforms (mainly biosensors based on electrochemical detection and paper-based strips for optical readout). In all instances, the applications selected are focused on communicable diseases, including foodborne pathogens and mycobacteria. Therefore, two paper-based platforms in different configurations (nucleic acid lateral and vertical flow) are compared in terms of the analytical performance for the detection of Mycobacterium. In order to achieve a further improvement in the limit of detection, the preconcentration of the bacteria is performed by immunomagnetic separation. Secondly, the simultaneous detection of Salmonella and E. coli by nucleic acid lateral flow with visual readout and electrochemical genosensing are evaluated and compared in terms of their analytical performance. Although these methods required double-tagging PCR for amplification, portable, battery-powered thermocyclers can easily be adapted for resource-constrained settings to meet the demands for ASSURED diagnosis. Furthermore, the synthesis of Magnetic Molecularly Imprinted Polymers, in order to replace biological-modified magnetic particles is also presented in this dissertation, taking as a model the detection of biotin and biotinylated molecules with outstanding performance. Moreover, the characterization of the material is performed by different analytical techniques and compared, in all instances, with the non-imprinted polymer. This biomimetic material shows a great potential for the preconcentration and detection of a huge range of analytes. Despite all these progress, nucleic acid amplification techniques are still necessary to reach the challenging limits of detection required in some communicable disease. Isothermal amplification techniques are good candidates to bring sensitive diagnostic tests in places where the PCR can be a barrier. In detail, the electrochemical genosensing of E. coli based on isothermal amplification is also described in this dissertation. In this approach, the electrochemical readout by square-wave voltammetry on disposable electrodes is optimized comparing two different labelling approaches. It is important to highlight that all these strategies aim to be used as tools for the improvement of rapid diagnostic test in low resource settings, to interrupt the chain of infection of communicable diseases and enabling the rapid treatment.
APA, Harvard, Vancouver, ISO, and other styles
9

Tang, Shenglan, John Ehiri, and Qian Long. "China's biggest, most neglected health challenge: non-communicable diseases." BioMed Central, 2013. http://hdl.handle.net/10150/610162.

Full text
Abstract:
BACKGROUND:Over the past two decades, international health policies focusing on the fight against the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), tuberculosis (TB), malaria, and those diseases that address maternal and child health problems, among others, have skewed disease control priorities in China and other Asian countries. Although these are important health problems, an epidemic of chronic, non-communicable diseases (NCDs) in China has accounted for a much greater burden of disease due to the ongoing rapid socioeconomic and demographic transition.DISCUSSION:Although NCDs currently account for more than 80% of the overall disease burden in China, they remain very low on the nation's disease control priorities, attracting marginal investment from central and local governments. This leaves the majority of patients with chronic conditions without effective treatment. International organizations and national governments have recognized the devastating social and economic consequences caused by NCDs in low- and middle-income countries, including China. Yet, few donor-funded projects that address NCDs have been implemented in these countries over the past decade. Due to a lack of strong support from international organizations and national governments for fighting against NCDs, affected persons in China, especially the poor and those who live in rural and less developed regions, continue to have limited access to the needed care. Costs associated with frequent health facility visits and regular treatment have become a major factor in medical impoverishment in China. This article argues that although China's ongoing health system reform would provide a unique opportunity to tackle current public health problems, it may not be sufficient to address the emerging threat of NCDs unless targeted steps are taken to assure that adequate financial and human resources are mapped for effective control and management of NCDs in the country.SUMMARY:The Chinese government needs to develop a domestically-driven and evidence-based disease control policy and funding priorities that respond appropriately to the country's current epidemiological transition, and rapid sociodemographic and lifestyle changes.
APA, Harvard, Vancouver, ISO, and other styles
10

Zulu, Tryphine. "Socioeconomic inequalities in non-communicable diseases in South Africa." Doctoral thesis, Faculty of Health Sciences, 2019. https://hdl.handle.net/11427/31799.

Full text
Abstract:
Non-communicable diseases (NCDs) have reached epidemic proportions globally and in South Africa. This thesis is situated within the health equity framework. The aim is to assess the extent of wealth related inequalities in NCDs and to assess the impact of the social determinants of health in mediating these inequalities. Data from the first South African National Health and Examination Survey (SANHANES-1) and wave 4 of the South African National Income Dynamics Study (NIDS) were used. The methods used include the concentration curve, concentration index and decomposition analysis to assess the drivers of socioeconomic inequality in NCDs and some causes of NCDs including smoking, obesity, high blood pressure; use of screening services and effective coverage for hypertension management. The prevalence of smokers is 18.7%, the population average BMI is 26.38 kg/m2, and the prevalence of hypertension is 29.7%. The distribution of these risk factors is pro-wealthy with concentration indices ranging from 0.048 for hypertension, 0.057 for smoking prevalence to 0.115 for obesity. While these risk factors are prevalent amongst the wealthy, the outcomes are worse amongst the poor. The concentration index for expenditure on cigarettes is strongly pro-poor, (-0.130) compared to the prowealthy smoking prevalence. The hypertensive poor suffer more severe hypertension with a concentration index of -0.054 for depth and -0.079 for severity, respectively. Obesity affects the wealthiest the most. However, the overweight adults who are poor tend to suffer more severe obesity as shown by a relatively smaller concentration index of depth (0.015) and severity (0.033) respectively. The overall utilisation of screening services is below 50% for eligible respondents. The two wealthiest quintiles benefit disproportionately more than they should, given their share of the population. This is particularly true for diabetes and cholesterol with a concentration index of 0.27 for cholesterol, 0.129 for diabetes and 0.052 for hypertension. Adults that do not take up screening services are predominantly the black race group, poor, rural, male, unemployed and uninsured. Only 23% of those with hypertension are diagnosed, on treatment and are controlled. Wealth-related variables such as education, wealth, health insurance coverage and province of residence drive most of the observed pro-wealthy inequalities in this thesis. Wealthier adults benefit to a larger extent from the care cascade, compared to the poor. Therefore, until there is a substantial increase in early diagnosis and effective treatment, high levels of mortality from NCDs will persist in South Africa. And until the poor are prioritised through radical policy change in all economic sectors, the observed inequalities will continue.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Communicable diseases"

1

Cook, G. C. Communicable and tropical diseases. London: Heinemann Medical Books, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Communicable Disease Surveillance Centre (Northern Ireland), ed. Review of communicable diseases. Belfast: The Centre, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cook, G. C. Communicable and tropical diseases. London: Heinemann Medical, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Burma. Kyamʻʺ mā reʺ Ṭhāna Ññvhanʻ krāʺ reʺ Vanʻ Ruṃʺ. Control of communicable diseases. Rangoon: Central Press, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1931-, Armstrong Donald, and Cohen J. 1949-, eds. Infectious diseases. London: Mosby, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Association, American Public Health. Control of communicable diseases manual. Washington, DC: American Public Health Association, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hurster, Madeline M. Communicable and non-communicable disease basics: A primer. Westport, Conn: Bergin & Garvey, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ball, A. P. Infectious diseases. Edinburgh: Churchill Livingstone, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Heymann, David L. Control of communicable diseases manual. Washington, DC: American Public Health Association, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

L, Kasper Dennis, Fauci Anthony S. 1940-, and Harrison Tinsley Randolph 1900-1978, eds. Harrison's infectious diseases. New York: McGraw-Hill Medical, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Communicable diseases"

1

Ramirez, Amelie G., Ian M. Thompson, and Leonel Vela. "Communicable Diseases." In The South Texas Health Status Review, 17–31. Cham: Springer International Publishing, 2013. http://dx.doi.org/10.1007/978-3-319-00233-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Abbara, Aula. "Communicable Diseases." In Handbook of Refugee Health, 198–200. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9780429464874-9-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jones, Kelvyn, and Graham Moon. "Communicable diseases." In Health, Disease and Society, 146–89. London: Routledge, 2022. http://dx.doi.org/10.4324/9781003283010-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Barker, Emi N., and Marta Costa. "Communicable Diseases." In One Health for Veterinary Nurses and Technicians, 88–116. GB: CABI, 2023. http://dx.doi.org/10.1079/9781789249477.0005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Baker, Richard. "Communicable diseases." In Primary Health Care and Population Mortality, 76–100. Boca Raton: CRC Press, 2023. http://dx.doi.org/10.1201/9781003355380-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ip, Eric C. "Communicable Diseases." In The Law and Regulation of Public Health, 103–44. London: Routledge, 2023. http://dx.doi.org/10.4324/9781003044741-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schoenfarber, Adam, and Sheila Langan. "Communicable Diseases." In Essential Clinical Social Work Series, 63–86. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-31650-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zhang, Rongguang. "Communicable Diseases Epidemiology." In Textbook of Clinical Epidemiology, 197–211. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-3622-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Reddy, Amulya. "Non-communicable Diseases." In Handbook of Refugee Health, 275–76. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9780429464874-11-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ip, Eric C. "Non-Communicable Diseases." In The Law and Regulation of Public Health, 173–89. London: Routledge, 2023. http://dx.doi.org/10.4324/9781003044741-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Communicable diseases"

1

Thudawehewa, H. R., U. C. B. Pathmakulasooriya, W. A. P. T. Jayawardhana, C. G. Wellehewa, Chamari Silva, and Pasangi Rathnayake. "Non-Communicable Diseases Detection System." In 2021 3rd International Conference on Advancements in Computing (ICAC). IEEE, 2021. http://dx.doi.org/10.1109/icac54203.2021.9671162.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mathur, Iti, Hemant Darbari, and Nisheeth Joshi. "Domain Ontology Development for Communicable Diseases." In Third International Conference on Computer Science & Information Technology. Academy & Industry Research Collaboration Center (AIRCC), 2013. http://dx.doi.org/10.5121/csit.2013.3640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cesario, Manuel, Matthew Jervis, Saturnino Luz, Masood Masoodian, and Bill Rogers. "Time-based Geographical Mapping of Communicable Diseases." In 2012 16th International Conference on Information Visualisation (IV). IEEE, 2012. http://dx.doi.org/10.1109/iv.2012.30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Erna, Mutiara, and Dr Syarifah. "Non-Communicable Diseases in Medan City 2016." In 2nd International Conference on Social and Political Development (ICOSOP 2017). Paris, France: Atlantis Press, 2018. http://dx.doi.org/10.2991/icosop-17.2018.33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Olshevskaya, A. V., M. Yu Gapon, N. V. Gapon, M. M. Zhdanova, A. T. Rybak, A. V. Vershinina, S. A. Marchenko, A. E. Аzhinov, and D. V. Rudoy. "RECOGNITION OF THE STATE OF CROPS USING NEURAL NETWORK MONITORING TOOLS." In STATE AND DEVELOPMENT PROSPECTS OF AGRIBUSINESS. ООО «ДГТУ-Принт» Адрес полиграфического предприятия: 344003, г. Ростов-на-Дону, пл. Гагарина,1., 2024. http://dx.doi.org/10.23947/interagro.2024.115-118.

Full text
Abstract:
Plant disease is any harmful condition that affects the appearance or function of a plant. The symptoms of the disease may depend on its cause, nature and location of the lesion. The factors causing plant diseases may be biotic and abiotic in nature. Non-communicable diseases are caused by unfavorable growth conditions; they are not transmitted from a diseased plant to a healthy one. Infectious diseases, on the contrary, can spread from one susceptible host to another, since the pathogen can multiply in the plant or on its surface. With the advent of modern diagnostic approaches, technologies based on the use of artificial intelligence will make it possible to diagnose diseases of crops in the early stages Keywords. Diagnostics, plant diseases, artificial intelligence, agricultural crops.
APA, Harvard, Vancouver, ISO, and other styles
6

Shaw, Rahul, Tufan Saha, and Himadri Nath Saha. "Automated Bio-Geographical Alert System-For Communicable Diseases." In 2018 IEEE 9th Annual Information Technology, Electronics and Mobile Communication Conference (IEMCON). IEEE, 2018. http://dx.doi.org/10.1109/iemcon.2018.8615046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Srinivasan, S., S. Selvakumar, Pacha Shobha Rani, and D. JayaKumar. "Performance evaluation of classifiers for non communicable diseases." In 11TH ANNUAL INTERNATIONAL CONFERENCE (AIC) 2021: On Sciences and Engineering. AIP Publishing, 2023. http://dx.doi.org/10.1063/5.0110516.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Davis-Street, Janis, Perla Manlapaz, Amelia Shannon, and Olubukunola Adebola Fagade. "Addressing Cardiovascular Disease Global Employer's Approach to Non- Communicable Diseases." In International Conference on Health, Safety and Environment in Oil and Gas Exploration and Production. Society of Petroleum Engineers, 2012. http://dx.doi.org/10.2118/156849-ms.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rahmy, Hafifatul Auliya, Azrimaidaliza, Eva Yuniritha, and Rifza. "Blended Learning Development of Non-Communicable Diseases Dietetics Subject." In The 3rd International Conference on Educational Development and Quality Assurance (ICED-QA 2020). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/assehr.k.210202.060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sangkatip, Worawith, and Jiratta Phuboon-Ob. "Non-Communicable Diseases Classification using Multi-Label Learning Techniques." In 2020 5th International Conference on Information Technology (InCIT). IEEE, 2020. http://dx.doi.org/10.1109/incit50588.2020.9310978.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Communicable diseases"

1

Baskoro, Danang, Leonardus Gandawijaya, and Kwartarini Yuniarti. Hypnotic Based Intervention for people with Non-Communicable Diseases : A scoping review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2021. http://dx.doi.org/10.37766/inplasy2021.3.0040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ng, Shu Wen, Thomas Hoerger, and Rachel Nugent. Preventing Non-communicable Diseases Using Pricing Policies: Lessons for the United States from Global Experiences and Local Pilots. RTI Press, May 2021. http://dx.doi.org/10.3768/rtipress.2021.pb.0025.2105.

Full text
Abstract:
Preventing non-communicable diseases (NCDs) in an effective and sustainable way will require forward-looking policy solutions that can address multiple objectives. This was true pre–COVID-19 and is even more true now. There are already examples from across the globe and within the United States that show how these may be possible. Although there are still many unknowns around how the design, targeting, level, sequencing, integration, and implementation of fiscal policies together can maximize their NCD prevention potential, there is already clear evidence that health taxes and particularly sugar-sweetened beverage (SSB) taxes are cost-effective. Nonetheless, policies alone may not succeed. Political will to prioritize well-being, protections against industry interference, and public buy-in are necessary. If those elements align, pricing policies that consider the context in question can be designed and implemented to achieve several goals around reducing consumption of unhealthy SSBs and foods, narrowing existing nutritional and health disparities, encouraging economic and social development. The US and its local and state jurisdictions should consider these pricing policy issues and their contexts carefully, in collaboration with community partners and researchers, to design multi-duty actions and to be prepared for future windows of opportunities to open for policy passage and implementation.
APA, Harvard, Vancouver, ISO, and other styles
3

Arrieta, Alejandro, and Ariadna García Prado. Series of Avoidable Hospitalizations and Strengthening Primary Health Care: The Case of Chile. Inter-American Development Bank, December 2012. http://dx.doi.org/10.18235/0006952.

Full text
Abstract:
This paper studies the effect of ambulatory and hospital coinsurance rates on HACSC among individuals with private insurance in Chile. During the last decade, Chile's private health sector has experienced a dramatic increase in its hospitalization rates, growing at four times the rate of ambulatory visits (see graph 1). Such evolution has raised concern among policy makers, interested in promoting more preventive services, and a major use of ambulatory care. The growth on the prevalence of chronic diseases has also set up the alarm. A burden disease study made in 2007 shows that 84% of the total diseases in the country were non-communicable diseases (Universidad Católica de Chile, 2008). The 2003 National Health Survey showed that only a small fraction of those affected by a chronic disease had their condition under control (Bitrán et al, 2010). In this context, coinsurance can be a valuable tool for dealing with cost escalating problems in the health system while, at the same time, promoting more ambulatory visits and preventive services and less HCSC.
APA, Harvard, Vancouver, ISO, and other styles
4

Fraanje, Walter, and Tara Garnett. What is ultra-processed food? And why do people disagree about its utility as a concept? Edited by Helen Breewood. Food Climate Research Network, July 2019. http://dx.doi.org/10.56661/ca3e86f2.

Full text
Abstract:
The increasing consumption of industrially processed convenience foods, soft drinks, and fast foods has been associated with a rise in non-communicable diseases, overweight and obesity. This building block explores the concept of ultra-processed food: how it has been defined, and differing views as to whether it is a useful way of thinking about food and its relation to health and wider sustainability concerns.
APA, Harvard, Vancouver, ISO, and other styles
5

Kapoor, Rati, Nishmeet Singh, Phuong Hong Nguyen, S. K. Singh, L. K. Dwivedi, Sarang Pedgaonkar, Parul Puri, Alka Chauhan, Shweta Khandelwal, and Sylvie Chamois. How is India doing on malnutrition and non-communicable diseases? Insights from the National Family Health Surveys 2005-06 to 2019-21. Washington, DC: International Food Policy Research Institute, 2022. http://dx.doi.org/10.2499/p15738coll2.136565.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zhang, Mingzhu, Wujisiguleng Bao, Luying Sun, Zhi Yao, and Xiyao Li. Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: meta-analysis of randomized clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0020.

Full text
Abstract:
Review question / Objective: To assess the beneficial effect and safety of finerenone for patients with chronic kidney disease associated with type 2 diabetes. Condition being studied: Chronic kidney disease (CKD) is a major contributor to morbidity and mortality from non-communicable diseases, affecting almost 700 million people worldwide. Approximately 40% of patients with diabetes have CKD, which exposes them to a 3-fold higher risk of cardiovascular death versus those with T2D alone. Strategies to protect the kidneys of patients with CKD and T2D may reduce their risk of cardiovascular events. Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced composite kidney and cardiovascular outcome in trials involving patients with chronic kidney disease. Recently, quite a few clinical studies have been conducted to compare finerenone and placebo. Our meta-analysis aimed to investigate the efficacy and safety of finerenone in chronic kidney disease associated with T2D. 1st author* - Mingzhu Zhang and Wujisiguleng Bao contributed equally to this study.
APA, Harvard, Vancouver, ISO, and other styles
7

FEDOTKINA, S. A., O. V. MUZALEVA, and E. V. KHUGAEVA. RETROSPECTIVE ANALYSIS OF THE USE OF TELEMEDICINE TECHNOLOGIES FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF HYPERTENSION. Science and Innovation Center Publishing House, 2021. http://dx.doi.org/10.12731/978-0-615-67320-2-4-22.

Full text
Abstract:
Introduction. The economic losses associated with disability due to diseases of the circulatory system, as well as the costs of providing medical care to patients suffering from heart and vascular diseases, are increasing annually. The state preventive measures currently being carried out are of a delayed nature. The results of the medical examination of the population of the Russian Federation in recent years (2015-2019) indicate that the incidence of cardiovascular diseases, including hypertension, is at a fairly high level. In the middle of the last century, the Concept of risk factors for the development of chronic non-communicable diseases were formulated, in the structure of which cardiovascular diseases, including arterial hypertension, occupies one of the primary positions. The concept is based on the results of promising epidemiological studies, and, at present, is a methodological basis for planning and organizing primary prevention of cardiovascular diseases. The purpose of the study. Based on the analysis of literary sources (including foreign ones) containing experience in the use of telemedicine technologies, to assess their significance for the prevention, diagnosis and treatment of hypertension, as well as forecasting improvements in the quality of medical care when adapting to the use of clinical recommendations. Materials and methods. The article provides an analytical review of the use of modern telemedicine technologies in the prevention of hypertension. The results of the study and their discussion. The analysis of literary sources has shown that in the context of the progress of information and telecommunication technologies in the healthcare system, a fundamentally new direction has appeared in the organization and provision of medical care to the population - telemedicine, which will ensure the modern level of prevention, detection and treatment of chronic non-communicable diseases, and also determines positive medical, social and economic performance indicators. To date, updates in the legislative framework of the Russian Federation are aimed at ensuring that medical care with the use of telemedicine technologies is more widespread, taking into account the standards of medical care and clinical recommendations. Conclusion. Based on a review of literature sources, it has been established that the modern solution to the problem of improving the quality of medical care for patients, including those with hypertension, diseases is medical care using telemedicine technologies that prove their medical, social and economic effectiveness.
APA, Harvard, Vancouver, ISO, and other styles
8

Keshav, Dr Geetha, Dr Suwaibah Fatima Samer, Dr Salman Haroon, and Dr Mohammed Abrar Hassan. TO STUDY THE CORRELATION OF BMI WITH ABO BLOOD GROUP AND CARDIOVASCULAR RISK AMONG MEDICAL STUDENTS. World Wide Journals, February 2023. http://dx.doi.org/10.36106/ijar/2405523.

Full text
Abstract:
Introduction: Advancements and increase in access to healthcare have increased the life expectancy in India from 32 years in 1947 to almost 70 years currently. Due to robust vaccination and basic health programs, most of the communicable diseases are kept under control. The disease burden is now skewed towards non-communicable diseases. It is an established fact that body mass index (BMI) is a reliable predictor of cardiovascular disease (CVD) later in life. Early prediction can decrease the disease load and enable early preventative measures. A more novel approach of connecting it with blood groups would yield profound results in predictability and subsequent management. This study was done to see correlation between BMI and known blood groups in order to predict the potential incidence of CVDs in medical students. Material and Method - A cross-sectional descriptive study was conducted in Bhaskar Medical College from September 2022 - November 2022. The sample population included 150- 1st year medical students chosen by Randomized sampling method. BMI was calculated based as weight in kilograms divided by the square of the height in meters (kg/m2). Discussion - Many studies conducted on the association of Blood groups with BMI yielded mixed and inconclusive results. On analysis of the data obtained from this study, O- positive blood group showed the highest inclination towards obesity i.e. 30 of the total participants. A-positive and B- positive blood groups were shown to have a lesser association with obesity i.e. 11 participants of the 150. These results were in accordance with a study done among female students by Shireen Javad et.al, nding blood group O to be the most prone to obesity.8 Incompatible to our results, a study conducted by Samuel Smith Isaac Okai et.al. found no signicant association between blood groups and BMI.10 Another study conducted by Christina Ravillo et.al. found that blood group O had the highest and blood group AB with lowest prevalence of obesity9. These ndings were similar to the results obtained in our study. To study the correlation of BMI with ABO blood group and Cardiovascula AIMS and OBJECTIVES Aim: - r risk among medical students. 1. Calculate and segregate the participants according to BM Objectives: - I using the standard formula provided by the WHO. 1. Determine Blood group using antisera 2. Evaluation of Lipid prole in obese individuals
APA, Harvard, Vancouver, ISO, and other styles
9

Farhan, Jakub Ali, Piotr Kaczyński, and Maciej Perkowski. Public Perception of Healthy Food in The Light of Interdisciplinary Scientific Certainty. Survey report. Wydawnictwo Prawo i Partnerstwo, 2023. http://dx.doi.org/10.15290/pphflisc.2023.

Full text
Abstract:
In recent years, an alarming trend in the rising incidence of non-communicable diseases has led to increased interest in the issue of so-called "healthy food". Despite the enormity of food regulation, the concept of "healthy food" is not framed in any legal framework, and the public's understanding of it is uneven. So what is "healthy food" according to the public? This report contains the results of a survey aimed at answering this question. The survey consisted of two parts - on the one hand, a representative sample of 1,041 people was surveyed, and on the other hand, 100 food entrepreneurs were surveyed. The obtained results of the survey provide the research team with a starting point for further interdisciplinary research (legal sciences, chemical sciences, medical sciences) in the "healthy food" problem area.
APA, Harvard, Vancouver, ISO, and other styles
10

Luoto, Jill, Mario Sánchez, Marco Stampini, Jonathan Cali, Diana M. Pinto, Frederico C. Guanais, Pablo Ibarrarán, and Katherine Grace Carman. Applying Behavioral Tools to the Design of Health Projects. Inter-American Development Bank, July 2014. http://dx.doi.org/10.18235/0008508.

Full text
Abstract:
This technical note discusses how behavioral economics insights can be used to enhance the design of health interventions, with emphasis on those addressing non-communicable diseases, by promoting behavioral changes. These interventions are neither sophisticated nor costly, and are particularly suited for cases in which individuals are seemingly not making rational choices about their health. The main contribution of this note is the attempt to orient non-expert practitioners in the analysis of the problem and design of the intervention. For this purpose, we provide a novel framework to map common behavioral biases and barriers that have limited the success of traditional interventions (i.e., bounded rationality, bounded willpower, and bounded selfishness) to the most promising solutions identified in the existing literature (e.g., framing, commitment contracts, and social incentives).
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Communicable diseases' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography